BioAge Labs BIOA
NASDAQ BIOA
$5.52 -0.04 (-0.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) EBIT Margin (2025 - 2026)

Updated

BioAge Labs' EBIT Margin came in at -1196.78% for Q2 2026, down 169.79 percentage points from -1026.99% a year earlier and down 281.37 percentage points from the prior quarter.

Analysis

BioAge Labs (BIOA) EBIT Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioAge Labs reported EBIT Margin of -1026.28%, up 1337.92 percentage points year-over-year; for FY2025, it came in at -1031.46%.

  • Business Quant data shows BIOA's EBIT Margin at -915.40% (Q1 2026), -923.42% (Q4 2025) and -1126.58% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 BioAge Labs 245.72 Mn -1.55 Bn -14.23 Mn -1,196.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,196.78%
Mar 31, 2026 -915.40%
Dec 31, 2025 -923.42%
Sep 30, 2025 -1,126.58%
Jun 30, 2025 -1,026.99%
Mar 31, 2025 -1,133.43%
API Access

BioAge Labs EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=BIOA&period=max&api_key=YOUR_API_KEY